Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BZP/TFMPP and alcohol effects on driving performance
ACTRN12606000504516Phase 3Recruiting
- Sponsor
- Ministry of Health
- Start
- Mar 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of 1-benzylpiperazine, trifluoromethylphenylpiperazine and ethanol (4 arms), sponsored by Ministry of Health. Primary endpoints: Standard deviation of lateral position, Confusion score and 3 more. Started Mar 2006; status: recruiting.
02
Drugs
1-benzylpiperazinetrifluoromethylphenylpiperazineethanol
Beyond the preview
Go deeper on ACTRN12606000504516.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12606000504516.